1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AVALO THERAPEUTICS INC
Avalo Therapeutics Inc
XNAS: AVTX
16.62 0.45 (2.78%)
166.8K
XNAS Volume

XNAS 22 Sep, 2026 11:46 AM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Avalo Therapeutics Inc is on 24 Sep 2026 for the purpose of Stifel 2026 Virtual Immunology and Inflammation Forum See details

Avalo Therapeutics Inc - AVTX - stock price prediction, stock price target, analyst ratings from 14 analysts

Avalo Therapeutics Inc has a share price target of US$ 44 and profit growth estimate of -42.1% for Unknown Year, based on top 14 analyst calls.